Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, ...

In the carefully monitored confines of a clinical facility, patients with schizophrenia took what looked like an ordinary ...

In a review study, researchers reported that omega-3 supplements may lessen the severity of schizophrenia symptoms in teens and young adults, especially those with low levels of omega-3s.

Synapse-restoring pill set for human trials as novel schizophrenia treatment A once-a-day pill that regenerates lost nerve cell connections is being trialed as a schizophrenia treatment DALL-E ...

In a Phase III clinical trial conducted by MIT spinout Lyndra Therapeutics, the researchers used the once-a-week pill to deliver a widely used medication for managing the symptoms of schizophrenia ...

Supplements that may improve symptoms of schizophrenia and its treatment include omega-3 fatty acids, B vitamins, vitamin E, zinc, magnesium, and N-acetylcysteine.

For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by Bristol Myers Squibb will be called ...

After decades of antipsychotic drugs, a new FDA-approved treatment for schizophrenia targets a different brain system—with ...

A Phase 3 clinical trial of a new once-weekly risperidone pill for schizophrenia shows it delivers comparable therapeutic effects to daily treatment, offering improved convenience and potential ...

In several studies, only 40% to 60% of people with schizophrenia stay on track with their daily meds. Long-acting drugs solve the problem of having to take medicine every day.

For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by Bristol Myers Squibb will be called ...

MIT researchers developed a pill that can be taken once a week instead of daily, gradually releasing medication from within the stomach. In a phase 3 clinical trial, the treatment maintained ...